Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy

Curr Oncol Rep. 2003 Mar;5(2):79-80. doi: 10.1007/s11912-003-0091-x.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Cancer, Regional Perfusion*
  • Clinical Trials as Topic
  • Extremities
  • Humans
  • Limb Salvage / methods
  • Melanoma / therapy*
  • Melphalan / therapeutic use
  • Multicenter Studies as Topic
  • Neovascularization, Pathologic / therapy
  • Sarcoma / therapy*
  • Skin Neoplasms / therapy*
  • Soft Tissue Neoplasms / therapy*
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / therapeutic use*

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Tumor Necrosis Factor-alpha
  • Melphalan